1. Home
  2. ANEB vs COEP Comparison

ANEB vs COEP Comparison

Compare ANEB & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANEB
  • COEP
  • Stock Information
  • Founded
  • ANEB 2020
  • COEP 2017
  • Country
  • ANEB United States
  • COEP United States
  • Employees
  • ANEB N/A
  • COEP N/A
  • Industry
  • ANEB Biotechnology: Pharmaceutical Preparations
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ANEB Health Care
  • COEP Health Care
  • Exchange
  • ANEB Nasdaq
  • COEP Nasdaq
  • Market Cap
  • ANEB 36.7M
  • COEP 32.4M
  • IPO Year
  • ANEB 2021
  • COEP N/A
  • Fundamental
  • Price
  • ANEB $1.33
  • COEP $12.45
  • Analyst Decision
  • ANEB Buy
  • COEP
  • Analyst Count
  • ANEB 1
  • COEP 0
  • Target Price
  • ANEB $8.00
  • COEP N/A
  • AVG Volume (30 Days)
  • ANEB 12.7K
  • COEP 115.6K
  • Earning Date
  • ANEB 02-21-2025
  • COEP 03-25-2025
  • Dividend Yield
  • ANEB N/A
  • COEP N/A
  • EPS Growth
  • ANEB N/A
  • COEP N/A
  • EPS
  • ANEB N/A
  • COEP N/A
  • Revenue
  • ANEB N/A
  • COEP N/A
  • Revenue This Year
  • ANEB N/A
  • COEP N/A
  • Revenue Next Year
  • ANEB N/A
  • COEP N/A
  • P/E Ratio
  • ANEB N/A
  • COEP N/A
  • Revenue Growth
  • ANEB N/A
  • COEP N/A
  • 52 Week Low
  • ANEB $0.80
  • COEP $2.31
  • 52 Week High
  • ANEB $3.30
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • ANEB 36.62
  • COEP 63.21
  • Support Level
  • ANEB $1.45
  • COEP $8.65
  • Resistance Level
  • ANEB $1.61
  • COEP $12.95
  • Average True Range (ATR)
  • ANEB 0.12
  • COEP 1.64
  • MACD
  • ANEB -0.03
  • COEP -0.16
  • Stochastic Oscillator
  • ANEB 0.00
  • COEP 75.25

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: